BAKER BROS. ADVISORS LP CymaBay Therapeutics, Inc. Transaction History

BAKER BROS. ADVISORS LP portfolio value:

$7.59M
portfolio value

BAKER BROS. ADVISORS LP quarter portfolio value change:

+18.64%
quarter

CymaBay Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 1.19M $3.5 2.17M
Q2 2022 share 0.00% 0 shares -347K $2.95 2.17M
Q1 2022 share 0.00% 0 shares -586K $3.11 2.17M
Q4 2021 share 0.00% 0 shares -586K $3.3 2.17M
Q3 2021 share 0.00% 0 shares -1.54M $3.65 2.17M
Q2 2021 share 0.00% 0 shares -391K $4.36 2.17M
Q1 2021 share Decrease -24.98% -722.81K shares -6.75M $4.54 2.17M
Q4 2020 share Decrease -11.05% -359.26K shares -6.94M $5.74 2.89M
Q3 2020 share Increase +113.59% 1.72M shares 18.23M $7.24 3.25M
Q2 2020 share Increase 0.00% 1.52M shares 5.31M $3.49 1.52M
Q4 2019 share Decrease -100.00% -5.70M shares -29.22M $1.96 0
Q3 2019 share 0.00% 0 shares -11.64M $5.12 5.70M
Q2 2019 share 0.00% 0 shares -34.92M $7.16 5.70M
Q1 2019 share Increase +16.06% 789.71K shares 37.09M $13.28 5.70M
Q4 2018 share 0.00% 0 shares -15.78M $7.87 4.91M
Q3 2018 share 0.00% 0 shares -11.50M $11.08 4.91M
Q2 2018 share Increase +25.53% 1M shares 15.10M $13.42 4.91M
Q1 2018 share Increase +30.95% 925.92K shares 23.36M $12.99 3.91M
Q4 2017 share 0.00% 0 shares 3.41M $9.2 2.99M
Q3 2017 share Increase +131.60% 1.7M shares 16.67M $8.06 2.99M
Q2 2017 share Decrease -8.61% -121.72K shares 1.36M $5.76 1.29M
Q1 2017 share Increase +357.05% 1.10M shares 5.54M $4.3 1.41M
Q4 2016 share Increase 0.00% 309.26K shares 535K $1.73 309.26K